Epidemiological Impact of Nirsevimab on Admissions for Bronchiolitis in a Pediatric Emergency Department: A Single-Center Cohort Study
Viruses · 16.04.2026 · 18 (4) · 469
DOI: 10.3390/v18040469 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Viruses, online erschienen am 16.04.2026. Verfasst von Emanuele Castagno und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Emergency, Regina Margherita Children's Hospital, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Bronchiolitis, Emergency Service, Hospital, Respiratory Syncytial Virus Infections, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis in children < 24 months and a major public health concern, causing high rates of Emergency Department (ED) visits, hospitalizations, and Pediatric Intensive Care Unit (PICU) admissions. Nirsevimab is a recombinant monoclonal antibody recommended for all infants and high-risk children < 24 months. A retrospective single-center cohort study was conducted to evaluate the impact of nirsevimab introduction on bronchiolitis epidemiology in an Italian tertiary pediatric ED, accounting for 40,000 admissions/year. All children < 24 months who presented to our ED with bronchiolitis during two consecutive RSV seasons (first season: 1 October 2023 to 30 April 2024; second season: 1 October 2024 to 30 April 2025) were included. Descriptive and multivariate analyses are reported. Overall, 484 patients were analyzed (336 in 2023–2024; 148 in 2024–2025), with immunization coverage reaching 87.5% by April 2025. Compared with the previous season, RSV positivity decreased significantly (32.4% vs. 47.9%; p = 0.003) and was lower in immunized children (16.2% vs. 51.5%; p < 0.001). Immunization was associated with a reduced risk of RSV-positive swab in the second season (OR = 0.159, 95% CI: 0.059–0.397). Among RSV-negative patients, other respiratory viruses increased (p < 0.001), while co-infections increased in RSV-positive cases (p = 0.021). Hospitalization rates remained stable, though absolute admissions were halved. In conclusion, nirsevimab immunization reduced RSV burden, supporting its inclusion in universal prevention programs and the need for multicenter prospective studies to assess long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Emergency, Regina Margherita Children's Hospital, 10126 Turin, Italy.
- Department of Pediatrics and Public Health Sciences, Postgraduate School of Pediatrics, University of Turin, 10126 Turin, Italy.
- Department of Pediatrics, Regina Margherita Children's Hospital, University of Turin, 10126 Turin, Italy.
- Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
- Department of Pediatrics and Public Health Sciences, University of Turin, 10126 Turin, Italy.
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, 10126 Turin, Italy.
ORCID-Profile: Emanuele Castagno, Lorenzo Milani, Rosanna Irene Comoretto, Irene Raffaldi, Marco Spada, Franca Fagioli
Zitieren
APA
Castagno, E., Aschieri, C., Ferri, I., El Khbazi, S., Milani, L., Comoretto, R. I., Raffaldi, I., Tardivo, I., Spada, M., Bondone, C., & Fagioli, F. (2026). Epidemiological Impact of Nirsevimab on Admissions for Bronchiolitis in a Pediatric Emergency Department: A Single-Center Cohort Study. Viruses, 18(4), 469. https://doi.org/10.3390/v18040469
Vancouver
Castagno E, Aschieri C, Ferri I, El Khbazi S, Milani L, Comoretto RI, et al. Epidemiological Impact of Nirsevimab on Admissions for Bronchiolitis in a Pediatric Emergency Department: A Single-Center Cohort Study. Viruses. 2026;18(4):469. doi:10.3390/v18040469
BibTeX
@article{Castagno2026,
author = {Castagno, Emanuele and Aschieri, Carola and Ferri, Irene and El Khbazi, Sara and Milani, Lorenzo and Comoretto, Rosanna Irene and Raffaldi, Irene and Tardivo, Irene and Spada, Marco and Bondone, Claudia and Fagioli, Franca},
title = {Epidemiological Impact of Nirsevimab on Admissions for Bronchiolitis in a Pediatric Emergency Department: A Single-Center Cohort Study},
journal = {Viruses},
year = {2026},
volume = {18},
number = {4},
pages = {469},
doi = {10.3390/v18040469}
}
EUVIMED